Yu Zhao

Dr. Yu Zhao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
HCHui-Hui Chai
Hui-Hui Chai
YZYu Zhao
Yu Zhao
ZZZeng Zeng
Zeng Zeng
RYRuizhong Ye
Ruizhong Ye
QHQiao-Hong Hu
Qiao-Hong Hu
CPCheng-Zhong Peng
Cheng-Zhong Peng
Chai HH, et al. Korean J Radiol. 2022 May;23(5):555-565. https://doi.org/10.3348/kjr.2021.0716

19 January 2022 in Gene
Verified
Journal Article
Open access
YZYimiao Zhu
Yimiao Zhu
YZYu Zhao
Yu Zhao
ZCZhongsheng Cao
Zhongsheng Cao
ZCZhihao Chen
Zhihao Chen
WPWensheng Pan
Wensheng Pan
In primary stomach adenocarcinoma (STAD), the tumor immune microenvironment (TIME) is important for cancer occurrence and progression; however, its clinical significance remains unclear. This study investigated the association between patient survival, TIME, and therapeutic response to STAD. Gene expression profiles of STAD cases were collected from the Cancer Genome Atlas (TCGA) database and Gene Expression Omnibus. Molecular subtypes were explored with consistent clustering methods according to 119 immune signatures and the infiltrating scores of 22 immune cells using the Multi-Omics Immuno-Oncology Biological Research algorithm. We determined IFNγ scores and immune cytolytic activity (CYT) scores on the basis of corresponding gene signatures via single-sample Gene Set Enrichment Analysis. Comparisons of survival, TIME, 10 immunity-related oncogenic pathways, immune checkpoint expression, and therapeutic response were conducted among the three subtypes. We further applied linear discriminant analysis to construct a characteristic index to classify the subtypes, and the Pearson correlation coefficient for the relationship between the index and immune checkpoint genes. Weighted Correlation Network Analysis (WGCNA) was used to mine the associated modules and specific genes. We collected gene expression profiles from 352 STAD cases in the TCGA database, 300 in GSE62254, and 344 in GSE84437. Three STAD subtypes (IS1-IS3) were established according to the TIME signatures. The IS3 subtype had the highest immune score and the best prognosis, as well as markedly increased immune T-cell CYT, Th1/IFNγ scores, and immune checkpoint gene expression, compared to the other two subtypes. It was highly similar to the PD-1 response group in the previous study samples of GSE91061. The established TIME classification index performed well in classifying subtypes and was directly proportional to immune checkpoint-related gene expression levels. WGCNA explored 6 modules and 14 genes, namely DYSF, MAN1C1, HTRA3, EMCN, RFLNB, KANK3, MAGEH1, CD93, PCAT19, FUT11, BMP1, FOSB, DCHS1, and TCF3, which were associated with the established TIME classification index and STAD patient prognosis. TIME phenotypes of STAD patients could be divided into three different molecular subtypes, which displayed different prognoses, immune features, and therapeutic responses. Our results shed new light on predicting patient outcomes and the discovery of new anti-STAD therapeutic strategies according to the TIME.

1 June 2021 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
YZYimiao Zhu
Yimiao Zhu
JTJiangfeng Tu
Jiangfeng Tu
YZYu Zhao
Yu Zhao
JJJiyong Jing
Jiyong Jing
ZDZhiyuan Dong
Zhiyuan Dong
WPWensheng Pan
Wensheng Pan
Purpose: The guidelines recommend urgent biliary drainage (BD) for severe acute cholangitis, without a clear definition of “urgent”. To explore the optimal time, we identified the impact of timing of BD on clinical outcomes in severe acute cholangitis. Patients and Methods: A retrospective study of patients with severe acute cholangitis was conducted based on the Multiparameter Intelligent Monitoring in Intensive Care III (MIMIC-III) database. Multivariable regressions were used to identified the effect of timing of BD on in-hospital mortality, 30-day mortality, and the length of stay (LOS) in hospital and the intensive care unit (ICU) with adjustment for confounding factors. Results: A total of 106 severe acute cholangitis patients underwent BD with a median time of 14.14 hours (IQR: 7.60– 32.59). Among them, 67.9% were performed within 24 hours and 80.2% within 48 hours. Median length of stay was 2.65 days (IQR: 1.70– 5.12) in the ICU and 7.54 days (IQR: 4.49– 17.17) in hospital. The in-hospital and 30-day mortality rates were 13.2% and 14.2%, respectively. On multivariate analysis, every 1-day delay of BD increased 1.49 days of stay in hospital (P< 0.0001). Delayed BD (> 48 hours) was linked with 5.56 days longer ICU LOS (P = 0.0096), while urgent BD (< 24 hours) did not significantly shorten the ICU stay (P = 0.0997). No significant increase was observed on in-hospital mortality (OR = 1.03; 95% CI 0.93– 1.13) nor 30-day mortality (OR=1.01; 95% CI 0.87– 1.14) with BD delay in this population. Conclusion: In severe acute cholangitis patients, delay in BD increased in-hospital LOS. BD after 48 hours was associated with longer ICU LOS. Yet, BD within 24 hours did not significantly reduce the mortality nor shortened the ICU LOS.

20 October 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
ZHZhenping Han
Zhenping Han
TLTingting Li
Tingting Li
SWSiyi Wang
Siyi Wang
LGLi Gao
Li Gao
YHYing Hu
Ying Hu
JYJieping Yan
Jieping Yan
Multiple endocrine neoplasia type 1 (MEN1) is a syndrome characterized by the occurrence of two or more endocrine gland tumors. Here, we show a case of a 52-year-old man diagnosed with MEN1 through gastrinoma, parathyroid adenoma and gene detection. The MEN1 patient’s case was complicated with relapsed primary hyperparathyroidism (PHPT), and they received ultrasound-guided radiofrequency ablation (RFA). The patient had a remarkable recovery after RFA treatment for the relapsed PHPT. It might be an alternative treatment for MEN1 patients with poor conditions such as high surgical risk, unwillingness to choose parathyroid surgery or those unable to tolerate surgery. Individualized therapy significantly benefits the prognosis of MEN1 patients.

1 January 2022 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
YGYunfen Ge
Yunfen Ge
TBTapas Ranjan Behera
Tapas Ranjan Behera
MYMing Yu
Ming Yu
SXShuyang Xie
Shuyang Xie
YCYue Chen
Yue Chen
QSQuanquan Shen
Quanquan Shen
We aimed to evaluate the role of higher mean arterial pressure (MAP) during cardiopulmonary bypass (CPB) in preventing development of acute kidney injury (AKI). Methods. We evaluated a population of elderly individuals >60 years of age undergoing CPB to find correlation of MAP during CPB with development of AKI after the surgery. Patients who experienced sustained low MAP during the CPB defined as that of 65 mmHg for their outcome with regard to AKI. The KDIGO criteria were used to define presence of acute kidney injury. Results. Of the total 92 patients, 50 were in the low‐pressure group and 42 were in the high‐pressure group. The MAP was 61.14 ± 5.54 mmHg in the low‐pressure group and 68.97 ± 3.65 mmHg in the high‐pressure group (p < 0.001). 13 (26%) in the low‐pressure group and 17 (40.48%) in the high‐pressure group developed AKI (p = 0.140). Male sex was associated with an increased incidence of cardiac surgery‐associated AKI (p = 0.034). Conclusions. A higher MAP in the range of 65–75 mmHg during the cardiopulmonary bypass does not significantly prevent acute kidney injury in elderly patients undergoing cardiac valve surgery.

23 September 2025 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
YZYu Zhao
Yu Zhao
YZYimiao Zhu
Yimiao Zhu
CNChao Ni
Chao Ni
LWLijun Wang
Lijun Wang
CYChenyan Yan
Chenyan Yan
LWLijuan Wang
Lijuan Wang
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.